First AD

Second AD

Biomarker Testing in BTC: Approaches and Practices Across Academic and Community Clinicians

Video content above is prompted by the following: 

In your clinical practice, what type of biomarker testing are you performing (liquid vs tissue vs both; DNA vs RNA NGS)?

Please comment on any differences and/or similarities in practice regarding (early) biomarker testing in BTC.

Clinical

® Clinical Focus page includes a listing of all specialities covered across  OncLive.com, including breast cancer, lung cancer, gastrointestinal cancers, genitourinary cancers, hematologic malignancies, and gynecologic cancers. Each individual specialty page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances in both the localized and metastatic settings, and ongoing research.


Video Series

Exploring Biliary Tract Cancer: Top Takeaways From ASCO GI 2025 

Peer Exchange

Panelists discuss how clinicians are increasingly utilizing both tissue and liquid biopsies with comprehensive DNA/RNA next-generation sequencing (NGS) for biomarker testing in biliary tract cancer (BTC), while noting variations in testing practices across different treatment centers.